[{"Assets_0_Q2_USD":3697695000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":95107000.0,"NetIncomeLoss_1_Q2_USD":30841000.0,"NetIncomeLoss_2_Q2_USD":65307000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q2_shares":52153000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_2_Q2_shares":52545000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q2_shares":51841000.0,"WeightedAverageNumberOfSharesOutstandingBasic_2_Q2_shares":52238000.0,"StockholdersEquity_0_Q2_USD":1193238000.0,"EarningsPerShareBasic_1_Q2_USD":0.59,"EarningsPerShareBasic_2_Q2_USD":1.25,"EarningsPerShareDiluted_1_Q2_USD":0.59,"EarningsPerShareDiluted_2_Q2_USD":1.24,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":239357000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":493337000.0,"Ticker":"PBH","CIK":"1295947","name":"PRESTIGE CONSUMER HEALTHCARE INC.","OfficialName":"Prestige Consumer Healthcare Inc. Common Stock","form":"10-Q","period":"20180930","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2689675976.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20181101"}]